Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
Clinical trial NCT00309244 · COMPLETED
Trial details
- NCT number
- NCT00309244
- Sponsor
- Mannkind Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2008-08-01
- Enrollment
- 677
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.